Drug Discovery Informatics Market: Rapidly Evolving Industry…… COVID-19….



The global drug discovery informatics market size is expected to reach USD 2.07 billion by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 12.6% during the forecast period. Drug therapy is evolving in response to health care needs of the population. The most recent trend is to develop drugs for treatment of chronic diseases, especially those affecting the older population.
Biopharmaceutical innovators are at the forefront of the human response to the coronavirus pandemic. A significant number of major biotech firms are in the midst of a race to investigate the Sars-Cov-2 genome and prepare a viable vaccine for the same. As compared to the speed of response to SARS/MERs etc, the biotech entities are investigating SARs-Cov-2 at an unprecedented rate and a considerable amount of funds are being put into the R&D. With multiple candidates in trial, the public and private sectors are anticipated to work in unison for the foreseeable period, until a vaccine is developed for Covid-19. The report will account for Covid19 as a key market contributor.
Cardiovascular Diseases (CVDs), stroke, and cancer are the most prevalent health issues and also the most common conditions causing death. Moreover, treatment expenses and costs pertaining to these diseases are very high, which triggers the demand for effective novel molecules. In the U.S. alone, revenue generated through CVD treatments was over USD 444 billion in 2010, and it has been estimated to claim more lives each year than the remaining causes of death combined.
Major participants include Albany Molecular Research Inc.; Certara; Boehringer Ingelheim GmBh; Charles River Laboratories; Infosys; GVK Biosciences; Collaborative Drug Discovery Inc.; DiscoverX; ChemAxon; Jubilant Biosys; Novo Informatics; and Selvita.
Clinical decision support tools, which include online database for assistance in enhancement of clinical decisions, are timely updated and that significantly impacts market growth. Moreover, the World Health Organization's Consultative Expert Working Group for Research and Development is also involved in evaluation and development of open source drug discovery platforms. Introduction of open drug discovery tool kit (ODDT), which serves as a tool for computer-aided drug discovery by implementing machine learning scoring functions (RF-Score and NN-Score), is anticipated to work in favor of the market.
To Request Sample Copy of this report, click the link:
https://www.grandviewresearch.com/industry-analysis/drug-discovery-informatics-market/request/rs3
Further key findings from the report suggest:
·         Lead generation and lead optimization are anticipated to witness hand-in-hand growth owing to usage of similar IT solutions
·         Presence of different co-operation models, such as joint ventures, strategic partnership, price competition, and project selection, for outsourcing drug informatics solutions in the industry is influencing the growth of the market positively
·         North America is projected to hold prominent position in the arena throughout the forecast period. Higher incidence rates of different infectious diseases and oncology diseases are expected to drive the demand for informatics solutions to aid drug discovery and development. Presence of molecular R&D laboratories and market players in the U.S. is supplementing the growth of the regional market
·         Asia Pacific is likely to post the highest CAGR during the same period, owing to cost saving advantage offered by the region
·         Some of the key players operating in the market Boehringer Ingelheim GmBh; ChemAxon; Jubilant Biosys; Certara; Selvita; Novo Informatics; Albany Molecular Research Inc.; Infosys; DiscoverX; Collaborative Drug Discovery Inc; GVK Biosciences; and Charles River Laboratories.
The global drug discovery informatics market size was estimated at USD 713.4 million in 2016. It is anticipated to progress at a CAGR of 12.6% over the forecast period. Introduction of in silico tools, which enable computation with varied workflows that are in sync with rate of modern medicinal chemistry is one of the key trends stimulating market growth. Drug discovery is a functional process in pharmaceutical and biotechnology companies. It involves different steps and procedures that depend on in-silico tools for reducing the complexity of a process.
Identification of lead molecules requires synthesis and analysis of many derivatives that can be prepared with the help of in silico modeling tools. Success of a drug discovery experiment depends extensively on effectiveness of tools employed to assess varied aspects of drugs. In silico tools used herein include modeling tools for determination of 3D structures of ligand and protein-ADMET assessment-affinity estimation in docking and drug-ligand interaction for pharmacological profiling.
Major market participants are involved in adoption of in silico modeling tools, which is expected to work in favor of the market. In silico tools are promising tools that provide valuable structural screening and information validation at a fraction of the cost of traditional methods, shortening the discovery process to a great extent.
Migration from expensive and large mainframe computers as well as shared clusters to personal supercomputers, powerful desktops, small workgroup clusters, or laptops is extending the full potential of next-generation discovery information processing provided to a broader range of scientists. The onus is shifting to software developers, who need to create scientific software products that are easy to use, in order to most effectively exploit the power of inexpensive computing.
Browse Press Release of this report:
https://www.grandviewresearch.com/press-release/global-drug-discovery-informatics-market
Grand View Research has segmented the global drug discovery informatics market on the basis of workflow, mode, service:
Drug Discovery Informatics Workflow Outlook (Revenue, USD Million, 2014 - 2025)
·         Discovery Informatics
o    Identification & Validation Informatics Assay Development Informatics
o    Lead Generation Informatics
·         Development Informatics
o    Lead Optimization
o    FHD Preparation
o    Phase IA Informatics
o    Phase IB/2 Informatics
Drug Discovery Informatics Mode Outlook (Revenue, USD Million, 2014 - 2025)
·         In-house Informatics
·         Outsourced Informatics
Drug Discovery Informatics Service Outlook (Revenue, USD Million, 2014 - 2025)
·         Sequence Analysis Platforms
·         Molecular Modeling
·         Docking
·         Clinical Trial Data Management
·         Others
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.




Comments

Post a Comment

Popular posts from this blog

Foot Orthotic Insoles Market 2026: What Will Be Changes In Investment Ratio With Opportunity Analysis?? |Grand View Research, Inc.

Image
The global foot orthotic insoles market size is expected to reach USD 5.5 billion by 2026 , according to a new report by Grand View Research, Inc., exhibiting a 6.3% CAGR during the forecast period. Growing incidence of diabetes and plantar fasciitis are expected to drive the market over the forecast period. Moreover, rapid urbanization and increasing disposable income are anticipated to propel growth in future. Technological advancements, spurred by ongoing investments in R&D, are expected to increase growth potential in the coming years. Moreover, rise in geriatric population, which is susceptible to orthopedic disorders, is impelling product demand globally. For instance, in 2017 as per the U.S. Census Bureau, the number of people aged 65 or older increased by 1.6 million from 2014 to 2015. In addition, increasing incidence of sports injuries and rising prevalence of osteosarcoma in the region has led to the need for various orthotics devices, which is expected to drive ...
Read more

A Look into Smokehouse Industry……Deep Analysis…..

Image
The global smokehouse market size is anticipated to reach USD 157.2 million by 2025 , according to a new report by Grand View Research, Inc. The market is anticipated to register a CAGR of 2.2% during the forecast period. Rising need for a healthy lifestyle has led consumers to prefer griller or barbequed food over fried food and other kinds of fast food. This trend is expected to have a positive impact on the market growth. The home care & decor industry has been witnessing inconsistent growth, since the Covid 19 outbreak. As a result of the ongoing pandemic crisis, there has been a drop in the overall performance of discretionary products such as decorative fixtures, bedding products, to name a few. The virus outbreak has, however, led to substantial growth in categories such as cleaning and hygiene products. Prominent growth in the e-commerce business is also one of the positive influences of the outbreak, wherein companies are focusing on expanding their distribution ...
Read more

A Look into Shapewear Industry……Deep Analysis…..

Image
The global shapewear market size is expected to reach USD 3.80 billion by 2025 registering a CAGR of 7.7%, according to a new report by Grand View Research, Inc. The introduction of various products according to the type of garments is expected to support the market growth in the years to come. Growing target population across the globe is also augmenting the market growth. Changing lifestyle incurs increased investment in fitness and related accessories, which has positively impacted the market growth. The clothing, footwear, & accessories industry is anticipated to witness checkered growth throughout 2020, as a result of the unprecedented supply chain disruptions caused by the COVID-19 outbreak worldwide. The expected decline in the global sales of clothing, footwear, & accessories is attributable to massive supply chain disruptions across significant export markets, including China and India. However, the industry is likely to recover over the forecast timeframe,...
Read more